OUR PARTNERS

   

         

      

  

 

       

 

 

 

 

 

 

 

CONTACT US

PEPTIDE PRODUCTS NPCRIZ
LATVIA
DHL worldwide shipping
shop(a)npcriz.co

DISCOUNTS

our price 125,00 EUR (123,75 USD)
In Stock
our price 175,00 EUR (173,25 USD)
Out of Stock
our price 175,00 EUR (173,25 USD)
Out of Stock

NEW ARTICLES

arr32021 Respiro 180 Peptides / Respiro 3 Linguals. Taking care of the respiratory system With the onset of cold weather, we are susceptible to exacerbation of... arr32021 How to preserve your vision Cheerfulness, activity, dynamism and richness with life are indispensable attributes of the... arr32021 Changes in human sperm motility characteristics in the presence of Viorgon-18  Viorgon-18 V.V. Evdokimov1 , Е.А. Efremov1 , P.А. Elistratov2 , I.А. Yamskov2 , А.F.... arr32021 Viophtans: Structural aspects and chaperone activity ... arr32020 Viorgons. Prevention and assistance with various diseases. Strokes, heart attacks, traumatic brain injuries (operations).If there is a violation of the... arr32019 Oligopeptides and the nuances of their use This article is devoted to oligopeptides and the nuances of their use. Very often, talking about... arr32019 Healthy Liver - Healthy Skin! You can ask banal questions:How often do you wash your face?Do you brush your teeth?Do you clean... arr32019 Peptides NPCRIZ: Effective Protection of the Liver and Pancreas    The human body works as a single, well-coordinated mechanism and any failure in the work of... arr32019 Anti-age complex NB Anti-AGE Complex NB: The Secret of Stellar Excellence   Friends! It is time for a pleasant... arr32019 NEW PRODUCT Nose Balms "RINOLAX" Nose Balms "RINOLAX"DESCRIPTIONBalsams "Cleansing" and "Regenerating" - innovative, effective... arr32018 Cardiovascular disease prevention September 29, worldwide, at the initiative of the World Heart Federation, with the support of many... arr32018 Previn and Peptide complex 19 - a complex for the prevention of cardiovascular diseases September 29 all over the world, at the initiative of the World Heart Federation, with the support... arr32018 Antitumor effect of peptides The modern period of development of medicine is characterized by significant achievements in the... arr32018 Trap for fat Customer feedback:"I learned about it from my brother, who lost about 7 kg with his help. His... arr32018 Zhenoluten and Endoluten - solving problems related to menopause Want to delay the onset of menopause and stay healthy for a long time? Do not neglect the latest... arr32018 Cytamins is a novel dietary supplements. Cytamins - are products for people who care about their health and appearance. Preservation of... arr32018 Why does not standard cosmetics help? Why does not standard cosmetics help?peptide cosmetics, peptides Any good, modern cream can... arr32018 How do peptides work for weight loss? Peptides are chains of proteins responsible for metabolic processes in our body, as well as for... arr32018 Create protection for immunityCreate protection for immunity   And although the window is still September with a gentle sun and... arr32018 Which peptides are the most important President of the Gerontological Society at the Russian Academy of Sciences, Doctor of Medical... arr32018 Revilab Peptide ML - a series of multifunctional AGE-protectors !  Youth and beauty have long been synonymous with the word "health". Today, many of us are... arr32017 Recovering the liver with peptides is extremely important in the fallRecovering the liver with peptides is extremely important in the fall. The aggravation of many... arr32017 Endoluten - treatment of human reproductive disordersRelationship between epiphysis cycles and human ageepiphysis The epiphysis (pineal body) is a small... arr32017 NEW Cosmetics RevilabNEW Cosmetics Revilab The company NPCRIZ constantly cares about its customers and fans of products.... arr32017 Revilab peptide SL ‒ innovation of the future!Modern consumers live in an accelerated pace, value their time and strive for a quick result. Each... arr32017 I was returned to life by peptides NPCRIZ "My name is Zhibek Aidarbekova. I am 58 years old. I live in Almaty, I am a retired police major,... arr32017 Nomination for the Nobel PrizeProfessor Chavinson wanted to extend the life of his parents. Russian Professor Vladimir Havinson... arr32017 Regenart: Joints under protection Diseases of the spine and joints are becoming an increasingly urgent problem in modern society. In... arr32017 What is diabetes?Diabetes and peptides, diabetes treatment. Diabetes is a chronic disease associated with a... arr32017 Why the standard of cosmetics does not help? Any good, modern cream can improve the appearance of the skin because it has moisturizing,... arr32017 The difference between peptides like GHRP-2 and GHRP-6 from Chavinson peptidesAll bodybuilders must read this article!Ghrp peptides A few years ago the world of bodybuilding was... arr32017 Peptides in bodybuildingHormones take a leading position among drugs to increase muscle mass, burn fat and increase stamina.... arr32017 Antitumor activity of peptides. Peptides and cancerThe modern period of development of medicine is characterized by significant achievements in the... arr32017 About therapy of patients with chronic prostatitisIn both scientific and popular editions devoted to the problem of chronic prostatitis, there is a... arr32017 So what is the uniqueness of the peptides NPCRIZ Today, scientists know that aging and disease of an organism begins at the moment when stops... arr32017 A cure for old ageAging is a biological process which in contrast to the time influenced. People have always tried to... arr32017 Research peptides NPCRIZThe deterioration of the peptide Bioregulation in the body reduces its resistance to destabilizing... arr32017 The secret of life is in the nano-peptidesGerontologists Experts say that in homo sapiens, like biological species, the life limit is 110-120... arr32017 The peptides NPCRIZ in sports and bodybuildingNatural peptides of SPB of Institute of Bioregulation and gerontology are widely used in... arr32016 PEPTIDE geroprotectors - prevention of agingSt. Petersburg Institute of Bio-regulation and Gerontology,Saint Petersburg A typical sign of aging... arr32016 A model of complementary interaction of short peptides with the DNA double helixComparison of the spatial arrangement of functional groups of the nucleic bases on the surface of... arr32016 Peptides in cosmeticsPeptides can include not only medicines, but also in other products. For example, Russian scientists... arr32016 Why is all shown interest in peptide bioregulators? The interest on the part of scientists, doctors, beauty industry professionals, and ordinary... arr32016 Peptides NPCRIZ for the prevention and treatment of Zika VirusIn today's time when the world is attacked by new diseases, such as Zik Virus , the NPCRIZ company... arr32016 Serum for skin around the eyes №5Serum for skin around the eyes №5 green BeautifeyeTM and horse chestnut seed extract are directed... arr32016 WHAT IS REVITALIZATION ?Revitalization is a new direction in medicine, designed to facilitate the restoration, or rather,... arr32016 New products 2016  The range of natural peptide bioregulators added another novelty - geroprotector " Bonomarlot... arr32015 NEW Citomax-GlandokortThe complex of peptide fractions obtained from adrenal young animals. The isolated peptides have a...

MOST POPULAR

our price 27,00 EUR (26,73 USD)
In Stock
our price 56,00 EUR (55,44 USD)
In Stock



CLINICAL STUDY OF CERLUTEN

 
The dietary supplement Cerluten contains a complex of low-molecular peptides with molecular weight up to 5 000 Da, isolated from the brain tissues of young animals - calves aged up to 12 months. Cerluten is manufactured in the form of capsules with a content of active substances of 10 mg. 

Experimental studies have shown that the peptides possess tissue-specific action on the cells of the tissues from which they were isolated. Cerluten peptides regulate metabolism processes in the brain cells, increase brain safety margins, having a favorable effect on the organism adaptation processes in extreme conditions, the possess anti-oxidative properties, regulating peroxide oxidation processes in the brain cortex. So it is possible to extrapolate an efficiency of administration of Cerluten for restoration of the function of the central nervous system and its disorders of various origins. 

Treatment of central nervous system diseases is of specific urgency, because they lead to social adaptation disorder and invalidation of patients (2). Now the treatment of patients with disease of central nervous system diseases in view of pathogenetic mechanisms is carried out using the following traditional therapeutic agents of various action types(1, 3):

  • Influence on metabolism and integrative functions of the brain (cerebrolysin, piracetam, encephalolysate).
  • Normalization of cerebral and systemic circulation (stugeron, vinpocetine).
  • Reduction of psychopathological signs (meridin, amitriptilin).
  • Correction of changes of bioelectric activity of the brain (phenobarbital, convulex).
  • Influence on liquorodynamic disorders (veroshpiron, furosemide).
  • Prevention and inhibition of adhesive process (aloe, lidasa).
  • Correction of immunopathological reactions (levamisole, tavegil).

The clinical studies of Cerluten were carried out at the Medical Center of the Saint Petersburg Institute of Bioregulation and Gerontology of the Northwest Branch of the Russian Academy of Medical Sciences in 48 patients with various diseases of central nervous system: long-term effects of craniocerebral injury (the prescription of the injuries was from 1 year to 10 years), state after stroke, vascular encephalopathias, decrease in mental capacity, memory, attention during the period from October 2003 till February 2004. Distribution of the patients by clinical entities, sex and age is shown in the table 1. The patients of the main group have been taking Cerluten in addition to the general purpose medicines - 1-2 capsules, 2-3 times a day before meal for 10-20 days depending on intensity of the pathological process. 

The control group consisted of 37 similar patients, which have only general purpose treatment. All the patients have been taking symptomatic and pathogenetic drugs, these drugs have resulted in short-term therapeutic effect, which required increase in a dose of the drugs per treatment course and duration of their administration.

Table 1
Distribution of the patients by clinical entities, sex and age 

Examination methods
Cerluten efficiency was assessed by dynamics of subjective parameters and objectively, using correction task and electroencephalography (EEG) methods.

Examination results
After administration of Cerluten in patients of the main group the clinical result was observed in 64.6% of cases, satisfactory - in 22.9%, absence of positive effect - in 12.5% of cases (control group - table 2). There were no negative influences of Cerluten on a condition of the patients. 

Table 2
Cerluten efficiency in patients with diseases of central nervous system

At comparison of subjective parameters of the condition of the patients before and after use of Cerluten it was established that the number of health complaints was 2-3 times less. The patients have noticed memory impairment, intelligence impairment, decrease in intensity and duration of headache, emotional disbalance, endurance and stamina, feeling of rest after night sleep (table 3). In patients with consequences of craniocerebral injury and stroke there was a moderate regression of focal symptoms, improvement of speech function at motor and sensor aphasia, decrease in muscular spasticity. Comparative assessment of influence of Cerluten and other methods of treatment on the integral function of the brain - attention and bioelectric activity of the brain was assesses using correction task and electroencephalography accordingly.

Table 3
Influence of Cerluten on subjective parameters of the state of health of the patients.

Table 4
Influence of Cerluten on the dynamics of parameters of carrying out of correction task by the patients with diseases of central nervous system

The results of carrying out by the patients of the correction task after treatment using various methods are shown in table 4. According to the table, the patients after treatment using Cerluten have higher number of symbols viewed and lower number of errors. The patients of the main group have received better results at analysis of the dynamics of carrying out of correction task before and after the treatment in comparison with the patients of the control group. It was expressed by absence of violent oscillations of the number of the symbols viewed per similar time periods, presence of “warming-up” period to the middle of the task performance and gradual decline of the curve to the end of the task, which is a sign of highest attention stability after treatment.
Assessment of Cerluten influence on bioelectric activity of the brain was carried out using visual analysis of EEG with distribution by types and calculation of alpha index before and after the treatment. EEG was carried out selectively to the patients with more expressed signs of pathological processes. The examination results are shown in the table 5.

Table 5 
Cerluten influence on electorencephalogram type characteristic in patients with diseases of central nervous system

Before treatment the people examined in various groups predominantly had pathological EEG types (III, IV, V). III type of EEG was characterized by so called non-dominant curve at low amplitude level (below 30-35 mcV), presence of irregular alpha-activity or even its absence. IV type of EEG was characterized by particularly emphasized regularity of the rhythms, blurring of zonal differences. V type of EEG was characterized by presence of irregular slow activity with an amplitude over 35 mcV, sharp waves, paroxysmal discharges.
Patients after treatment using Cerluten had most intense changes of brain bioelectric activity. Is was seen on EEG first of all in the form of more clear modulation and restoration of zonal differences of alpha-rhythm, decrease in intensity of irritative processes, in some cases - elimination of paroxysmal discharges. 

Table 6 
Cerluten influence on the dynamic of alpha index changes in patients with diseases of central nervous system

Besides visual EEG assessment there was a calculation of alpha index in patients before and after treatment (table 6). It was established that under the influence of the treatment there was a reliable increase in the alpha index in the patients of the groups examined. However the decree of change of alpha index in patients, receiving different treatment was different. Alpha-index value was reliably higher in the group of patients after treatment using Cerluten® in comparison with the parameters in other groups.

Conclusion
On the basis of the data received it is justifiably to draw a conclusion that activation of reserve capacity of the brain cortex using Cerluten helps to improve integral functions of the brain. Thus the results of clinical study testify the efficiency and expediency of use of Cerluten for complex treatment and prophylaxis of the diseases of the central nervous system of various origins. Cerluten does not result in side effects, complications and drug dependence; there were no contraindications for carrying out of clinical studies. Cerluten can be used for treatment and prophylaxis, including in combination with any means of symptomatic therapy, used for neurological practice (vascular, nootropic, resolving, anticonvulsants, vitamins etc.) 

Recommendations for use
Cerluten is recommended for acceleration of restoration of the brain functions after the craniocerebral injury, stroke, intellectual disorders and the influence on the organism of various extreme factors. It’s also indicated to elderly people for maintenance of the mental capacity. It is recommended to take Cerluten per os 10-15 minutes before meals 1-2 capsules 2-3 times a day for 10-30 days. It may be desired to have one more course in 3-6 months. There are no contraindications and side effects for Cerluten administration.

References
1. Kovalev G.V. Nootropic medicines. - Volgograd: Nizh.-Volzh. publishing house, 1990. - 368 pages 
2. Treatment of nervous diseases: Translated from English/ Edited by V.K.Viderholt. - M.: Medicine, 1984. - 560 pages 
3. Mashkovsky M.D. Medicines: Pharmacotherapy for doctors, manual: 2 parts. - Vilnius: ZAO “Gamta”, 1993.X

 

NTE5NWY1Z